{"id":"https://openalex.org/W3211989211","doi":"https://doi.org/10.1016/s0140-6736(21)02317-5","title":"Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? \u2013 Authors\u2019 reply","display_name":"Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? \u2013 Authors\u2019 reply","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3211989211","doi":"https://doi.org/10.1016/s0140-6736(21)02317-5","mag":"3211989211","pmid":"https://pubmed.ncbi.nlm.nih.gov/34774142"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(21)02317-5","doi":"https://doi.org/10.1016/s0140-6736(21)02317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0140-6736(21)02317-5","pdf_url":"http://www.thelancet.com/article/S0140673621023175/pdf","source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"volume":null,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.thelancet.com/article/S0140673621023175/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070330715","display_name":"Prakash K. Bhuyan","orcid":"https://orcid.org/0000-0003-1937-9658","observed_orcids":["https://orcid.org/0000-0003-1937-9658"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prakash Bhuyan","raw_affiliation_strings":["Clinical Development, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015408835","display_name":"Jennie Medin","orcid":"https://orcid.org/0000-0002-7941-1675","observed_orcids":["https://orcid.org/0000-0002-7941-1675"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jennie Medin","raw_affiliation_strings":["BioPharmaceuticals Medical, AstraZeneca, Gothenburg SE431 83, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioPharmaceuticals Medical, AstraZeneca, Gothenburg SE431 83, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034150217","display_name":"Hugo Gomes da Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hugo Gomes da Silva","raw_affiliation_strings":["BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011651995","display_name":"Madhavi Yadavalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhavi Yadavalli","raw_affiliation_strings":["Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":null,"display_name":"Magnus Nord","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Magnus Nord","raw_affiliation_strings":["Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gothenburg SE431 83, Sweden. Electronic address: magnus.nord@astrazeneca.com","Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gothenburg SE431 83, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gothenburg SE431 83, Sweden. Electronic address: magnus.nord@astrazeneca.com","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gothenburg SE431 83, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"398","issue":"10313","first_page":"1801","last_page":"1802"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thrombosis-with-thrombocytopenia-syndrome","display_name":"thrombosis with thrombocytopenia syndrome","score":0.9890000224113464},{"id":"https://openalex.org/keywords/vaccine-induced-thrombocytopenia","display_name":"vaccine-induced thrombocytopenia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/chadox1-ncov-19-vaccine","display_name":"ChAdOx1 nCoV-19 vaccine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/azd1222","display_name":"AZD1222","score":0.9980000257492065},{"id":"https://openalex.org/keywords/case-definition","display_name":"case definition","score":0.5170000195503235},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.722000002861023},{"id":"https://openalex.org/keywords/thromboembolism","display_name":"thromboembolism","score":0.9800000190734863},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7614154815673828},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.6327992677688599},{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.6096752882003784},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.49753454327583313},{"id":"https://openalex.org/C83867959","wikidata":"https://www.wikidata.org/wiki/Q371467","display_name":"Scopus","level":3,"score":0.4729090631008148},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4466820955276489},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.4252590537071228},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4006234109401703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33110812306404114},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32955458760261536},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.2527707815170288},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000090985","descriptor_name":"ChAdOx1 nCoV-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014612","descriptor_name":"Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(21)02317-5","doi":"https://doi.org/10.1016/s0140-6736(21)02317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0140-6736(21)02317-5","pdf_url":"http://www.thelancet.com/article/S0140673621023175/pdf","source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:34774142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34774142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1016/s0140-6736(21)02317-5","doi":"https://doi.org/10.1016/s0140-6736(21)02317-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0140-6736(21)02317-5","pdf_url":"http://www.thelancet.com/article/S0140673621023175/pdf","source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320310094","display_name":"University of Washington","ror":"https://ror.org/00cvxb145"},{"id":"https://openalex.org/F4320320816","display_name":"Massey University","ror":"https://ror.org/052czxv31"},{"id":"https://openalex.org/F4320320992","display_name":"University of Canberra","ror":"https://ror.org/04s1nv328"},{"id":"https://openalex.org/F4320323692","display_name":"Oulun Yliopisto","ror":"https://ror.org/03yj89h83"},{"id":"https://openalex.org/F4320336503","display_name":"School of Life and Environmental Sciences, Deakin University","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3211989211.pdf","grobid_xml":"https://content.openalex.org/works/W3211989211.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W3184696594","https://openalex.org/W3187516448","https://openalex.org/W3193768668","https://openalex.org/W6799384007"],"related_works":["https://openalex.org/W3214111507","https://openalex.org/W4292239926","https://openalex.org/W4200290759","https://openalex.org/W3184696594","https://openalex.org/W4417165508","https://openalex.org/W4200140699","https://openalex.org/W4366407587","https://openalex.org/W4200284328","https://openalex.org/W3195702241","https://openalex.org/W3216458030"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-11-22T00:00:00"}